Jilin Jian Yisheng Pharmaceutical Co Ltd Tangible Net Worth Ratio
Jilin Jian Yisheng Pharmaceutical Co Ltd tangible net worth ratio. Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) has a Tangible Net Worth Ratio of 95.4% as of March 2026. This metric is calculated by deducting intangible assets (CN¥108.13 Million) from net assets (CN¥2.35 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Jilin Jian Yisheng Pharmaceutical Co Ltd (2006–2025)
Tangible net worth ratio of Jilin Jian Yisheng Pharmaceutical Co Ltd from 2006 to 2025. This chart shows how Jilin Jian Yisheng Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 20 annual periods from 2006 to 2025. As of March 2026, the ratio stands at 95.4%, reflecting net assets of CN¥2.35 Billion with intangible assets of CN¥108.13 Million CNY. Check Jilin Jian Yisheng Pharmaceutical Co Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Jilin Jian Yisheng Pharmaceutical Co Ltd Tangible Net Worth Ratio by Year (2006–2025)
Jilin Jian Yisheng Pharmaceutical Co Ltd tangible net worth ratio by year from 2006 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Jilin Jian Yisheng Pharmaceutical Co Ltd from 2006 to 2025, covering 20 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market cap of Jilin Jian Yisheng Pharmaceutical Co Ltd.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.3% | CN¥2.33 Billion | CN¥108.66 Million | CN¥2.96 Billion | ▲ +0.1 pp |
| 2024 | 95.2% | CN¥2.33 Billion | CN¥111.35 Million | CN¥2.97 Billion | ▲ +0.1 pp |
| 2023 | 95.1% | CN¥2.33 Billion | CN¥114.18 Million | CN¥3.05 Billion | ▲ +0.3 pp |
| 2022 | 94.8% | CN¥2.25 Billion | CN¥117.03 Million | CN¥2.97 Billion | ▲ +0.3 pp |
| 2021 | 94.5% | CN¥2.20 Billion | CN¥119.96 Million | CN¥2.86 Billion | ▲ +0.3 pp |
| 2020 | 94.2% | CN¥2.13 Billion | CN¥123.41 Million | CN¥2.80 Billion | ▼ -3.1 pp |
| 2019 | 97.3% | CN¥2.06 Billion | CN¥54.74 Million | CN¥2.50 Billion | ▲ +0.2 pp |
| 2018 | 97.2% | CN¥1.97 Billion | CN¥55.33 Million | CN¥2.55 Billion | ▲ +0.2 pp |
| 2017 | 97.0% | CN¥1.90 Billion | CN¥57.29 Million | CN¥2.65 Billion | ▲ +0.2 pp |
| 2016 | 96.8% | CN¥1.80 Billion | CN¥58.52 Million | CN¥2.67 Billion | ▲ +0.2 pp |
| 2015 | 96.6% | CN¥1.75 Billion | CN¥60.14 Million | CN¥2.63 Billion | ▼ -2.5 pp |
| 2014 | 99.1% | CN¥1.75 Billion | CN¥16.43 Million | CN¥2.49 Billion | ▲ +0.0 pp |
| 2013 | 99.0% | CN¥1.68 Billion | CN¥16.48 Million | CN¥1.89 Billion | ▲ +0.1 pp |
| 2012 | 98.9% | CN¥1.59 Billion | CN¥17.40 Million | CN¥1.66 Billion | ▼ -0.1 pp |
| 2011 | 99.0% | CN¥1.51 Billion | CN¥15.25 Million | CN¥1.58 Billion | ▲ +2.3 pp |
| 2010 | 96.7% | CN¥359.40 Million | CN¥11.77 Million | CN¥515.06 Million | ▲ +0.0 pp |
| 2009 | 96.7% | CN¥280.99 Million | CN¥9.22 Million | CN¥427.66 Million | ▼ -0.2 pp |
| 2008 | 96.9% | CN¥219.89 Million | CN¥6.82 Million | CN¥347.32 Million | ▲ +0.4 pp |
| 2007 | 96.5% | CN¥205.59 Million | CN¥7.27 Million | CN¥341.67 Million | ▼ -0.7 pp |
| 2006 | 97.1% | CN¥238.69 Million | CN¥6.83 Million | CN¥338.04 Million | — |